<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>1</startPage>
              <endPage>9</endPage>
              <doi>10.26663/cts.2020.0001</doi>
              <publisherRecordId>97</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Morbidity, mortality and survival rates of non-small cell lung cancer patients who underwent lobectomy with pulmonary artery reconstruction compared to those of the patients who underwent pneumonectomy</title>
                <authors>
                              <author>
                                <name>Hüseyin Ulaş Çınar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Celalettin  Kocatürk</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Levent  Cansever</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Süleyman  Ceyhan</name>
                                <affiliationId>4</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Ali Bedirhan</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Medicana International Hospital, Samsun, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Istinye University Medical Faculty, Liv Hospital Ulus, Istanbul, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Education and Research Center, Istanbul, Turkey</affiliationName><affiliationName affiliationId="4">Department of Thoracic Surgery, Bezmialem Vakif University, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Pulmonary artery reconstruction can be preferred as an alternative to pneumonectomy,
to spare the functional lung parenchyma in lung cancer. This study aimed to evaluate the morbidity,
mortality and survival rates of the patients who had undergone pulmonary artery reconstruction due to
central non-small cell lung cancer (NSCLC) and also to compare their data with those of the patients
who had undergone pneumonectomy.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; In this study, 88 patients who underwent pneumonectomy (group PN) and 20
patients who underwent standard or sleeve lobectomy (double sleeve) with pulmonary artery reconstruction
(group PAR) for NSCLC with stages I-IIIA between January 2005 and December 2010 were evaluated
retrospectively. The morbidity and mortality rates, durations of the hospital and intensive care unit stay,
5-year and mean survival rates of the homogenous patient groups were analyzed comparatively.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The postoperative morbidity rate was 30% in the PAR group and 53% in the PN group (p = 0.77).
The bronchial complication rate was 0% in the PAR group and 15% in the PN group (p = 0.04). The 30-day
mortality rate was 5% in the PAR group and 5.6% in the PN group (p = 1). The median follow-up period
for all patients was 31.5 months (range: 0-84 months) and total 5-year survival was 56.2%. In early-stage
tumors (stage I + stage II), total 5-year survival rate was 64% in the PAR group and 60% in the PN group
(p = 0.7). In late-stage tumors (stage III), total 5-year survival rate was 52% in the PAR group and 30% in
the PN group (p = 0.04). No local recurrence was observed in either group during the follow-up period.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; In central lung tumors, to avoid pneumonectomy, major anatomical lung resection with
pulmonary artery reconstructions can safely be performed with acceptable morbidity and mortality rates.
Oncological outcomes of pulmonary angioplasty procedures regarding survival and local recurrence are
not worse than those of pneumonectomy. Even in advanced stage lung tumors, these procedures can be
an alternative to more radical operations such as pneumonectomy.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=97</fullTextUrl>
              <keywords><keyword>pulmonary artery resection</keyword><keyword>pulmonary angioplasty</keyword><keyword>lung cancer</keyword><keyword>bronchoplasty</keyword><keyword>pneumonectomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>10</startPage>
              <endPage>15</endPage>
              <doi>10.26663/cts.2020.0002</doi>
              <publisherRecordId>98</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Investigation of clinical and genetic data of pectus excavatum in dysmorphological children: a single-center experience</title>
                <authors>
                              <author>
                                <name>Ahmet  Dumanlı</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muhsin  Elmas</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Afyonkarahisar Health Science University, Afyonkarahisar, Turkey</affiliationName><affiliationName affiliationId="2">Department of Genetics, Afyonkarahisar Health Science University, Afyonkarahisar, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Pectus excavatum (PE) is one of the most common chest wall deformations. However,
the pathogenesis of the disease is not completely understood and the results of the researches remain
inconsistent. There are not enough studies in the literature investigating the most common anomalies
accompanying PE. Thus, in this study, we aimed to evaluate the prenatal, natal, postnatal, genetic and
clinical findings associated with congenital PE.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Eighteen patients with PE (10 males, 8 females) who admits Afyonkarahisar
Health Sciences University were included in the study between 2012 and 2018. Patients were
investigated clinically, radiologically and genetically to determine the etiology and risk factors of PE.
PE is accompanied by several anomalies and has many systemic effects. The ages of the study patients
who applied to the dysmorphology clinic and included in the study ranged between 0 and 18. The
findings and genetic results of approximately 120 piece dysmorphological parameters of prenatal, natal
and postnatal periods of PE patients were investigated.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Five parameters associated with PE were recorded in this study, which include intrauterine
growth retardation (IUGR), high Beighton score, hypotonia, cryptorchidism and microcephaly.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Treatment of PE requires a detailed and multidisciplinary approach.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=98</fullTextUrl>
              <keywords><keyword>microcephaly</keyword><keyword>funnel chest</keyword><keyword>Noonan syndrome</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>16</startPage>
              <endPage>22</endPage>
              <doi>10.26663/cts.2020.0003</doi>
              <publisherRecordId>99</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Prognostic factors associated with morbidity and mortality after surgery for postintubation tracheal stenosis</title>
                <authors>
                              <author>
                                <name>Altan  Ceritoğlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Celal Bugra Sezen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Cemal  Aker</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Oguz  Girgin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hasan  Akın</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Education and Research Center, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; In this study, we reviewed the treatment, follow-up, and prognostic factors associated
with complications in patients who underwent tracheal resection due to postintubation tracheal stenosis
(PETS), in light of the literature.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Twenty-five patients who were operated for PETS between June 2012 and
June 2017 were retrospectively evaluated. The patients’ postoperative complications and prognostic
factors affecting mortality were examined.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;There was 11 female (44%) and 14 male (56%) patients. Eight patients (32%) had comorbidities.
The mean prolonged intubation time was 47.4 ± 55.0 minutes. Eight patients (32%) developed
postoperative morbidity. The main prognostic factors associated with morbidity were the length of the
stenotic area and the presence of endocrine and respiratory comorbidities (p&lt;0.05). Tracheal fistulae
were observed in 2 patients. The postoperative mortality rate was 8% (n=2). One patient with fistula
died on postoperative day 2, while another patient died at postoperative three months due to cardiac
failure. No significant factor was identified in relation to the development of tracheal fistulae.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt;The most important factor associated with complications was the presence of endocrine
comorbidities. Although tracheal surgery results in high rates of postoperative morbidity and mortality,
we believe these risks can be reduced by experienced surgeons and appropriate patient selection.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=99</fullTextUrl>
              <keywords><keyword>tracheal stenosis</keyword><keyword>postintubation</keyword><keyword>surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>23</startPage>
              <endPage>30</endPage>
              <doi>10.26663/cts.2020.0004</doi>
              <publisherRecordId>100</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Does sericin pleurodesis increase the basic fibroblastic growth factor and high-sensitive c-reactive protein levels in rat plasma?</title>
                <authors>
                              <author>
                                <name>Alkin  Yazicioglu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Serkan  Uysal</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Almila  Senat</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Tuba  Sahinoglu</name>
                                <affiliationId>4</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Furkan Sahin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Cemile  Biçer</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Özcan  Erel</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Erdal  Yekeler</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Ankara City Hospital, Ankara, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Hacettepe University, Faculty of Medicine, Ankara, Turkey</affiliationName><affiliationName affiliationId="3">Department of Biochemistry, Yildirim Beyazit University, Faculty of Medicine Ankara, Turkey</affiliationName><affiliationName affiliationId="4">Department of Thoracic Surgery, Konya Numune Hospital, Konya, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; This study investigates whether or not sericin pleurodesis increases basic fibroblastic
growth factor (bFGF) and high-sensitive C-reactive protein (hs-CRP) levels in rat plasma.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; A total of 42 adults, male, 12-week-old Wistar albino rats were obtained for the
study. The rats were divided randomly into three groups, as sericin, talcum powder, and control group.
After the administration of an anesthetic, the agents were administrated through a left thoracotomy.
The rats were sacrificed 12 days later through cardiac puncture. The bFGF and hs-CRP levels were
examined in plasma.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The mean rat plasma bFGF levels were 251.7 pg/mL in the sericin group (range: 101 to 821
pg/mL), 72.3 pg/mL in the talcum powder group (range: 24 to 131 pg/mL), and 133.1 pg/mL in the
control group (range: 32 to 320 pg/mL). A significant difference was noted in the results of a Scheffe
test between the sericin and talcum powder groups (p &lt; 0.05, p = 0.046). Mean rat plasma hs-CRP
levels were 1.038 ng/mL in the sericin group (range: 0.677 to 2.815 ng/mL), 1.343 ng/mL in the talcum
powder group (range: 0.606 to 5.662 ng/mL), and 0.945 ng/mL in the control group (range: 0.586 to
1.261 ng/mL), indicating no significant difference among the groups.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; It was found that bFGF levels were significantly higher in the sericin pleurodesis group
than in the talcum powder group, indicating the biochemical success of intrapleural sericin administration
in inducing pleurodesis. On the other hand, hs-CRP, a marker of inflammation, was not found to be
significant, indicating that hs-CRP returns to normal levels due to its short half-life.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=100</fullTextUrl>
              <keywords><keyword>sericin</keyword><keyword>fibroblast</keyword><keyword>fibrosis</keyword><keyword>growth factor</keyword><keyword>C-reactive protein</keyword><keyword>pleurodesis</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>31</startPage>
              <endPage>35</endPage>
              <doi>10.26663/cts.2020.0005</doi>
              <publisherRecordId>101</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Does frozen section increase false negativity in cervical mediastinoscopy during mediastinal lymph node staging compared to paraffin section?</title>
                <authors>
                              <author>
                                <name>Volkan  Erdoğu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muzaffer  Metin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Adnan  Sayar</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Songül  Büyükkale</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Ali  Kılıçgün</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Serda Kanbur Metin</name>
                                <affiliationId>4</affiliationId>
                              </author>
                              <author>
                                <name>Atilla  Pekçolaklar</name>
                                <affiliationId>5</affiliationId>
                              </author>
                              <author>
                                <name>Necati  Çıtak</name>
                                <affiliationId>6</affiliationId>
                              </author>
                              <author>
                                <name>Halide Nur Ürer</name>
                                <affiliationId>7</affiliationId>
                              </author>
                              <author>
                                <name>Atilla  Gürses</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Education and Research Center, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Memorial Şişli Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery, Bolu Abant İzzet Baysal University, Faculty of Medicine, Bolu, Turkey</affiliationName><affiliationName affiliationId="4">Department of Thoracic Surgery, University of Health Sciences, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="5">Department of Thoracic Surgery, Bursa City Hospital, Bursa, Turkey</affiliationName><affiliationName affiliationId="6">Department of Thoracic Surgery, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="7">Department of Pathology, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Education and Research Center, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Cervical Mediastinoscopy (CM) is the most important invasive method in mediastinal
lymph node staging. Lymph nodes dissected via CM can either be sent to frozen section (FS) for
analysis allowing thoracotomy to be performed on the same session, or to paraffin section (PS) where
thoracotomy is performed as a separate session (as a separate operation). This study compares the falsenegative
ratio of mediastinoscopic FS and PS analysis.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt;454 patients with primary lung cancer who have undergone CM between
January 2003 and December 2005 have been retrospectively analysed. This study evaluates whether FS
analysis increases the false-negative rate of lymph node biopsies.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;160 cases from the PS group and 113 cases from the FS group were included in the study. The
mean age of the patients was 56.4 years (range 28-77 years). There were 260 men and 13 women. In the
PS group, mean thoracotomy time after CM was 9.9 days. False negativity of CM in the PS and the FS
groups was found to be 9.2% and 8%, respectively.&lt;p&gt;
&lt;b&gt;Conclusion:&lt;/b&gt; There was no statistically significant difference in terms of false negativity between FS
and PS in mediastinal staging (p = 0.598).</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=101</fullTextUrl>
              <keywords><keyword>Frozen section</keyword><keyword>paraffin section</keyword><keyword>lung cancer staging</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>36</startPage>
              <endPage>39</endPage>
              <doi>10.26663/cts.2020.0006</doi>
              <publisherRecordId>102</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Thoracoscopic resection of a mediastinal lymphangioma: a rare case</title>
                <authors>
                              <author>
                                <name>Mustafa Vedat Doğru</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Umut  Kilimci</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Celal Buğra Sezen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Seyyit İbrahim Dinçer</name>
                                <affiliationId></affiliationId>
                              </author>
                              <author>
                                <name>Halide Nur Ürer</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Education and Research Center, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Pathology, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Education and Research Center, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">Lymphangiomas are often congenital benign tumors that are formed by abnormal proliferation and
development of lymphatic tissues. Although it may be localized in all lymphatic chain regions,
intrathoracic localization has been reported rarely. Here we present a case of a 24-year-old non-smoker
male patient admitted to our clinic with an incidentally found well-circumscribed radioopacity located
in the right upper zone of the mediastinal region detected on routine chest x-ray. The computerized
thorax tomography revealed a thin layered, fine-lined lesion with cystic content of 8x6 cm, located
at the right paratracheal level. The patient underwent a video-assisted thoracoscopic excision of the
cyst, and lymphangioma was confirmed based on the histopathologic examination. Although various
alternative treatment methods such as chemotherapy, radiotherapy, sclerosing therapy, and laser therapy
are used in the treatment of lymphangioma However, their effects on the treatment vary widely in the
reported publications.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=102</fullTextUrl>
              <keywords><keyword>cystic lymphangioma</keyword><keyword>mediastinum</keyword><keyword>video-assisted thoracoscopic surgery</keyword><keyword>minimally invasive surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>40</startPage>
              <endPage>42</endPage>
              <doi>10.26663/cts.2020.0007</doi>
              <publisherRecordId>103</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">What you don’t want to see after a superior sulcus tumor resection?: a tension pneumocephalus</title>
                <authors>
                              <author>
                                <name>Serkan  Yazgan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Soner  Gürsoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet  Üçvet</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Arkın  Acar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Özgür  Samancılar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Füsun  Özer</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Dr Suat Seren Chest Diseases and Surgery Medical Practice and Research Center, İzmir, Turkey</affiliationName><affiliationName affiliationId="2">Department of Neurosurgery, University of Health Sciences, Tepecik Medical Practice and Research Center, Izmir, Turkey</affiliationName></affiliationsList><abstract language="eng">A case of tension pneumocephalus following a superior sulcus tumor resection is presented. The symptoms, diagnostic methods, and treatment options are discussed and reviewed.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=103</fullTextUrl>
              <keywords><keyword>pneumocephalus</keyword><keyword>complication</keyword><keyword>superior sulcus tumor</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>43</startPage>
              <endPage>45</endPage>
              <doi>10.26663/cts.2020.0008</doi>
              <publisherRecordId>104</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">A rare case: castleman’s disease</title>
                <authors>
                              <author>
                                <name>Ezgi Çimen Çelik</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tarık  Yağcı</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet  Üçvet</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Soner  Gürsoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Zekiye  Aydoğdu</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, İzmir Dr. Suat Seren Chest Diseases and Thoracic Surgery Health Application and Research Center, İzmir, Turkey</affiliationName><affiliationName affiliationId="2">Thoracic Surgery Clinic, Kastamonu State Hospital, Kastamonu, Turkey</affiliationName><affiliationName affiliationId="3">Department of Pathology, University of Health Sciences, İzmir Dr. Suat Seren Chest Diseases and Thoracic Surgery Health Application and Research Center, İzmir, Turkey</affiliationName></affiliationsList><abstract language="eng">Castleman’s disease is angiofollicular lymph node hyperplasia that occurs as a result of abnormal
proliferation of plasma cells and B lymphocytes in lymphoid tissues. It has been shown to be associated
with HHV-8 and HIV infections and may be unicentric or multicentric. This case is presented due to its
rareness, good prognosis after complete surgery for unicentric type, and dramatically improved symptoms.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=104</fullTextUrl>
              <keywords><keyword>Castleman’s disease</keyword><keyword>mediastinal mass</keyword><keyword>HHV-8/HIV</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>46</startPage>
              <endPage>49</endPage>
              <doi>10.26663/cts.2020.0009</doi>
              <publisherRecordId>105</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">A rare case of giant thymolipoma</title>
                <authors>
                              <author>
                                <name>Şenol  Ürek</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>İrfan  Yalçınkaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Abdurrahim  Gördebil</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Süreyyapasa Chest Disease and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">Thymolipoma is one of the benign pathologies of the mediastinum that may reach large sizes over
time and even become a giant mass that fills the hemithorax. It may cause respiratory distress and even
failure, and may be accompanied by myasthenia gravis or other clinical conditions. Surgical excision of
the mass provides both diagnosis and treatment.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=105</fullTextUrl>
              <keywords><keyword>mediastinum</keyword><keyword>thymolipoma</keyword><keyword>surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-01-27</publicationDate>
              <volume>5</volume>
              <issue>1</issue>
              <startPage>50</startPage>
              <endPage>53</endPage>
              <doi>10.26663/cts.2020.00010</doi>
              <publisherRecordId>106</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Videothoracoscopic resection of a posterior mediastinal parathyroid adenoma in a patient with aberrant subclavian artery</title>
                <authors>
                              <author>
                                <name>Hüseyin  Mestan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Nevzat  Sertbaş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Serkan  Yazgan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Özgür  Samancılar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet  Üçvet</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Soner  Gürsoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Dr. Suat Seren Chest Disease and Thoracic Surgery Training and Research Hospital, Department of Thoracic Surgery, Izmir, Turkey</affiliationName></affiliationsList><abstract language="eng">Approximately 25% of the patients have an ectopic location of the parathyroid gland. In some cases,
hyperfunctional parathyroid glands may extend into the mediastinum that requires mediastinal surgical
exploration. A 66 years old woman presented with fatigue and raised serum calcium and parathormone
levels. Thorax computed tomography revealed a mediastinal mass and an aberrant right subclavian
artery (ARSA) which is the most common vascular anomaly of the aortic arch was demonstrated.
The mediastinal mass was evaluated in favor of parathyroid adenoma by parathyroid scintigraphy.
Videothoracoscopic resection of the adenoma was performed safely.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=106</fullTextUrl>
              <keywords><keyword>videothoracoscopy</keyword><keyword>parathyroid adenoma</keyword><keyword>aberrant subclavian artery</keyword>
                  </keywords>
            </record></records>